Biolotus Biotechnology AG is an independent, specialty biopharmaceutical company focused on global development and commercialisation of novel anti-infectives for women’s health.
Biolotus Biotechnology AG is based in Basel, Switzerland, home to a significant and growing biopharmaceutical sector.
Our first product, FemiFect® (pentamycin), a broad-spectrum macrolide antibiotic, is approved in Switzerland for the treatment of vaginitis.
Company Details
- Address
- Basel, Ch
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Basel
Biolotus Biotechnology Ag Questions
Biolotus Biotechnology Ag's LinkedIn profile is https://ch.linkedin.com/company/biolotus-biotechnology-ag
Biolotus Biotechnology Ag's industry is
Pharmaceutical Manufacturing
Biolotus Biotechnology Ag's top competitors are
Roche,
Innovelias Gmbh,
Applied Microbiology - Applied Sciences,
Cancer Research And Biotechnology Ag,
Algae-Culture,
Microalgae As,
Biogen,
Abbvie,
Atlas Biotechnology,
Nuance Biotechnology.
Biolotus Biotechnology Ag's categories are Pharmaceutical Manufacturing
